Comparative efficacy and safety of ferric carboxymaltose, iron sucrose and iron sorbitol in treatment of iron deficiency anemia in Indian pregnant women

Keval Ashok Patil; Manpreet Kaur Tehalia

doi:10.18203/2320-1770.ijrcog20222464

Authors

Keval Ashok Patil Department of Obstetrics and Gynecology, Matruseva Superspeciality Center, Miraj, Maharashtra, India http://orcid.org/0000-0003-3378-7287
Manpreet Kaur Tehalia Department of Obstetrics and Gynecology, Al Ameen Medical College and Hospital, Vijayapur, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20222464

Keywords:

Anemia, FCM, India, IDA, Iron sucrose, Pregnancy

Abstract

Background: There’s paucity of data on comparative efficacy and safety of ferric carboxymaltose (FCM), iron sucrose (IS) and iron sorbitol (ISr) in management of iron deficiency anemia (IDA) in pregnancy. Present study assessed the efficacy and safety of these iron preparations in management of IDA in Indian pregnant women.

Methods: This was a single-centre, parallel-group, open-label, randomised clinical trial. Total 150 pregnant women of 24 to 34 weeks of gestation with IDA and hemoglobin between 6.5 to <9.0g/dL, were randomised to three groups to receive either FCM, IS or ISr. Primary outcome was improvement in hemoglobin and serum ferritin levels with FCM, IS and ISr. Comparative improvement in other hematological parameters, tolerability and safety were also analysed.

Results: At 2 weeks, significant increase in hemoglobin of 1.86 g/dL was noted with FCM compared to 1.24 and 0.83 g/dL with IS and ISr respectively. At 6 weeks, increase in hemoglobin with FCM (4.02 g/dL) was almost two times of that with ISr (2.08 g/dL) and almost 1.4 times of that with IS (2.87g/dL). Significant improvement in serum ferritin was noted with FCM (25.59 µg/L) compared to IS (18.86 µg/L) and ISr (13.84 µg/L) at 2 weeks and also at 6 weeks (87.71 vs. 65.22 vs. 43.5 µg/L). Improvement in other hematological parameters was also significantly more with FCM compared to IS and ISr. Minor adverse effects were seen with IS and FCM. No serious adverse effects were reported in any group.

Conclusions: FCM 1000 mg rapidly corrects hemoglobin and replenishes iron stores in pregnant women with moderate to severe anemia reporting in third trimester.

Metrics

Metrics Loading ...

References

Kalaivani K. Prevalence and consequences of anaemia in pregnancy. Indian J Med Res. 2009;130(5):627-33.

Breymann C. Iron deficiency and anemia in pregnancy: Modern aspects of diagnosis and therapy. Blood Cells Mol Dis. 2002;29:506-16.

FOGSI general clinical practice recommendations. Management of iron deficiency anemia in pregnancy; 2016. Available at: https://www.fogsi.org/wp-content/uploads/2016/05/The-evidence-baseIDA-Pregnancy-24-May-2016-Clean.pdf. Accessed on 29, January 2021.

World health organization. micronutrient deficiency: prevention and control guidelines. Geneva, WHO; 2015. Available at: https://www.who.int/nutrition /topics/ida/en/. Accessed on 27t, January 2021.

National Family Health Survey Key findings from NFHS-5.;2020. 1st ed. Delhi: lnternational lnstitute for Population Sciences. Available at: http://rchiips.org/nfhs/factsheetNFHS-5.shtml. Accessed on 30 January 2021.

Singh P, Toteja GS. Micronutrient profile of Indian children and women: summary of available data for iron and vitamin A. Indian Pediatr. 2003;40(5):477-9.

Anand T, Rahi M, Sharma P, Ingle GK. Issues in prevention of iron deficiency anemia in India. Nutrition. 2014;30(7-8):764-70.

Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinatal Med. 2017;45(4):443-53.

Khalafallah AA, Dennis AE, Ogden K, Robertson I, Charlton RH, Bellette JM et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open. 2012;2(5).

Congdon EL, Westerlund A, Algarin CR, Peirano PD, Gregas M, Lozoff B et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012;160(6):1027-33.

Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346.

Pratt JJ, Khan KS. Non‐anaemic iron deficiency–a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol. 2016;96(6):618-28.

Erez Azulay C, Pariente G, Shoham-Vardi I, Kessous R, Sergienko R, Sheiner E. Maternal anemia during pregnancy and subsequent risk for cardiovascular disease. J Mat-Fetal Neonatal Med. 2015;28(15):1762-5.

Breymann C. Iron deficiency anemia in pregnancy. Sem hematol. 2015;52(4):339-47).

Beard J. Recent evidence from human and animal studies regarding iron status and infant development. J Nutrit. 2007;137(2):524S-30S.

Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Washington, DC: Ilsi Press. 1998.

Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Internal Med. 2010;268(3):286-95.

Chandra I, Sun LZ. Iron status and choice of iron therapy during pregnancy: Advantages and disadvantages. Int J Reproduct Contrac Obstetr Gynecol. 2015;4(5):1265.

Neogi SB, Devasenapathy N, Singh R, Bhushan H, Shah D, Divakar H et al. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Global Health. 2019;7(12):e1706-16.

National Rural Health Mission. Guidelines for control of Iron deficiency anaemia. 2013;6-30.

Scott LJ. Ferric carboxymaltose: a review in iron deficiency. Drugs. 2018;78(4):479-93.

Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2020;4.

Anemia Mukt Bharat. Anemia management protocol for pregnant women. Available at: https://anemiamuktbharat.info/home/interventions. Accessed on 21 June 2022.

Tandon R, Jain A, Malhotra P. Management of iron deficiency anemia in pregnancy in India. Ind J Hematol Blood Transfusion. 2018;34(2):204-15.

National Rural Health Mission. Guidelines for control of Iron deficiency anaemia. 2013;6-30.

Dhanani JV, Ganguly BP, Chauhan LN. Comparison of efficacy and safety of two parenteral iron preparations in pregnant women. J Pharmacol Pharmacotherap. 2012;3(4):314.

Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138(1):78.

Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinatal Med. 2012;40(5):469-74

Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregn Childbirth. 2014;14(1):1-5.

Froessler B, Gajic T, Dekker G, Hodyl NA. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Arch Gynecol Obstetr. 2018;298(1):75-82.

Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy-randomised controlled trial. BMC Pregn Childbirth. 2019;19(1):1-8.

Gupte SA, Venkataraman G, Shah AS, Mudholkar AS, Jangam SM. Clinical effects and safety of ferric carboxymaltose in pregnancy: An Indian real‐life experience. J Obstetr Gynaecol Res. 2021;47(10):3464-70.

Naqash A, Ara R, Bader GN. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials. BMC Womens Health. 2018;18(1):6.

Agrawal D, Masand DL. A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital. J Reprod Contracept Obstet Gynecol. 2019;8(6):2280-85.

Mahaur E. Comparative study of iron sucrose versus ferric Carboxymaltose in the management of iron deficiency Anaemia in pregnancy. Int J Clin Obstetr Gynaecol. 2020;4(3):148-52.

Patel A. A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anaemia during pregnancy. Int J Reprod Contracept Obstet Gynecol. 2020;9(6):2437-41.

Means RT. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020;12(2):447.